Cadavedo, Ian Rose .

HRN: 14-28-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
AMPICILLIN 1GM (VIAL)
09/19/2022
09/25/2022
IV
2 G
Q6
Post Term
Waiting Final Action 
09/20/2022
CEFUROXIME 1.5GM (VIAL)
09/20/2022
09/20/2022
IVT
1.5g
Loading Dose
CS
Waiting Final Action 
09/20/2022
CEFUROXIME 750MG (VIAL)
09/20/2022
09/23/2022
IVT
750mg
Q8 X 3 Days
S/P CS
09/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2022
09/23/2022
IV
500mg
Q8 For 3 Days
S/P CS MSAF
Waiting Final Action 
09/21/2022
CEFUROXIME 500MG (TAB)
09/21/2022
09/27/2022
PO
500MG
BID
S/P LTCS
Waiting Final Action 
09/21/2022
METRONIDAZOLE 500MG (TAB)
09/21/2022
09/27/2022
PO
500MG
TID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: